首页> 美国卫生研究院文献>other >A Novel Class of Bis- and Tris-Chelate Diam(m)inebis(dicarboxylato)platinum(IV) Complexes as Potential Anticancer Prodrugs
【2h】

A Novel Class of Bis- and Tris-Chelate Diam(m)inebis(dicarboxylato)platinum(IV) Complexes as Potential Anticancer Prodrugs

机译:一类新型的双-和三-螯合物双(m)inebis(二羧基二铂)铂(IV)配合物作为潜在的抗癌药物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A novel class of platinum(IV) complexes of the type [Pt(Am)-(R(COO)2)2], where Am is a chelating diamine or two monodentate am(m)ine ligands and R(COO)2 is a chelating dicarboxylato moiety, was synthesized. For this purpose, the reaction between the corresponding tetrahydroxidoplatinum(IV) precursors and various dicarboxylic acids, such as oxalic, malonic, 3-methylmalonic, and cyclobutanedicarboxylic acid, was utilized. All new compounds were characterized in detail, using 1D and 2D NMR techniques, ESI-MS, FTIR spectroscopy, elemental analysis, TGA, and X-ray diffraction. Their in vitro cytotoxicity was determined in a panel of human tumor cell lines (CH1, SW480 and A549) by means of the MTT colorimetric assay. Furthermore, the lipophilicity and redox properties of the novel complexes were evaluated in order to better understand their pharmacological behavior. The most promising drug candidate, >4b (Pt(DACH)(mal)2), demonstrated low in vivo toxicity but profound anticancer activity against both the L1210 leukemia and CT-26 colon carcinoma models.
机译:[Pt(Am)-(R(COO)2)2]类型的新型铂(IV)配合物,其中Am是螯合二胺或两个单齿am(m)ine配体,R(COO)2是合成了螯合的二羧酸基部分。为此目的,利用了相应的四氢氧化铂(IV)前体与各种二羧酸,例如草酸,丙二酸,3-甲基丙二酸和环丁烷二羧酸之间的反应。使用1D和2D NMR技术,ESI-MS,FTIR光谱,元素分析,TGA和X射线衍射对所有新化合物进行了详细表征。通过MTT比色测定法在一组人类肿瘤细胞系(CH1,SW480和A549)中确定了它们的体外细胞毒性。此外,对新型复合物的亲脂性和氧化还原特性进行了评估,以更好地了解其药理行为。最有前途的候选药物> 4b (Pt(DACH)(mal)2)具有较低的体内毒性,但对L1210白血病和CT-26结肠癌模型均具有很强的抗癌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号